Meyka Pro banner
Novartis AG

Stay Updated with the Latest Novartis AG NVS News in Real Time

Find NVS news now at Meyka AI. Stay informed with the latest Novartis AG stocks updates, including price news, market analysis, and expert insights.

NVSโ—NYSE
HealthcareDrug Manufacturers - General
$160.48
$2.78(1.70%)
U.S. Market is Open ยท 14:15
Roche Share Price Dips After UBS Downgrade to Neutral
๐Ÿ“… 10 days ago

Roche Share Price Dips After UBS Downgrade to Neutral

UBS cut Roche to Neutral on November 2 but raised its target to CHF 420. We explain why the Roche share price slipped to CHF 397.20, what giredestrant means and what analysts expect next.

Read more 12
Fed Interest Rate Decision: Fed Holds at 3.75โ€“4% as Hike Bets Grow
๐Ÿ“… 14 days ago

Fed Interest Rate Decision: Fed Holds at 3.75โ€“4% as Hike Bets Grow

The Fed interest rate decision kept rates at 3.75% to 4% in a 10-2 vote. We explain the December hike odds, the Swiss franc, and how stocks reacted.

Read more 12
Swiss Market Index Gains 0.07% on Iran Peace Deal, June 16
๐Ÿ“… 5 months ago

Swiss Market Index Gains 0.07% on Iran Peace Deal, June 16

SMI closes at 13,717.54 CHF on June 15 after U.S.-Iran peace deal. Oil prices fall 5%, supporting European market sentiment.

Read more 12
Swiss SMI Drops 1.75% on Iran Tensions, Pharma Stocks Fall
๐Ÿ“… 5 months ago

Swiss SMI Drops 1.75% on Iran Tensions, Pharma Stocks Fall

Swiss SMI index fell 1.75% to 13,305.40 on June 1 amid U.S.-Iran tensions. Pharma stocks dropped over 3% despite strong retail sales.

Read more 12
SMI Extends Winning Streak to 11 Days on Iran Peace Hopes, May 27
๐Ÿ“… 6 months ago

SMI Extends Winning Streak to 11 Days on Iran Peace Hopes, May 27

SMI rises 0.43% to 13,583.56 points on May 27, extending 11-day winning streak. Iran peace hopes and AI earnings support Swiss equities.

Read more 12
Bayer AG Stock Tumbles 5.4% as Earnings Pressure Mounts
๐Ÿ“… 6 months ago

Bayer AG Stock Tumbles 5.4% as Earnings Pressure Mounts

BAYN.SW stock drops 5.4% to CHF33.89 on weak earnings outlook and negative ROE. Healthcare sector weakness pressures pharma giant.

Read more 12
ObsEva S.A. (OBSN.SW) Tumbles 76.9% as Biotech Faces Clinical Trial Headwinds
๐Ÿ“… 6 months ago

ObsEva S.A. (OBSN.SW) Tumbles 76.9% as Biotech Faces Clinical Trial Headwinds

OBSN.SW stock crashes 76.9% to CHF0.0012 on SIX. ObsEva biotech faces clinical trial challenges in reproductive health pipeline.

Read more 12
Evotec SE (EVT.SW) Climbs 0.5% as Drug Developer Navigates Healthcare Headwinds
๐Ÿ“… 6 months ago

Evotec SE (EVT.SW) Climbs 0.5% as Drug Developer Navigates Healthcare Headwinds

EVT.SW stock rises 0.5% to CHF5.035 on SIX. Evotec SE faces profitability challenges but maintains market position in drug discovery.

Read more 12
Ypsomed Holding AG (YPSN.SW) Slips 1.5% Ahead of May 20 Earnings
๐Ÿ“… 6 months ago

Ypsomed Holding AG (YPSN.SW) Slips 1.5% Ahead of May 20 Earnings

YPSN.SW stock falls 1.5% to CHF298.4 on SIX ahead of earnings announcement May 20. Medical device maker faces valuation pressure.

Read more 12

NVS News FAQ